Xilio Therapeutics, Inc. (XLO) Financials
XLO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 77.8 million | 25.3 million |
2023-06-30 | 92.4 million | 25.0 million |
2023-03-31 | 111.5 million | 26.7 million |
2022-12-31 | 139.2 million | 33.5 million |
XLO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -13.4 million | 1.9 million |
2023-06-30 | -16.9 million | 1.8 million |
2023-03-31 | -25.4 million | 1.8 million |
2022-12-31 | -18.7 million | 1.8 million |
XLO Net Income
No data available :(
XLO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 59.8 million | - | 9.4 million |
2023-06-30 | 75.4 million | - | 9.7 million |
2023-03-31 | 93.3 million | - | 9.9 million |
2022-12-31 | 120.4 million | - | 10.1 million |
XLO Shares Outstanding
XLO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 11.1 million | 6.3 million | - |
2023-06-30 | 316000 | 13.2 million | 6.9 million | - |
2023-03-31 | 170000 | 16.1 million | 7.4 million | - |
2022-12-31 | 509000 | 15.0 million | 8.2 million | - |
XLO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 460000 |
2023-06-30 | - | 492000 |
2023-03-31 | - | 499000 |
2022-12-31 | - | 489000 |
XLO
Price: $1.05
52 week price:
Earnings Per Share: -2.96 USD
P/E Ratio: -0.22
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 18100
Market Capitalization: 35.2 million